Karl Lemström

5.1k total citations
159 papers, 3.6k citations indexed

About

Karl Lemström is a scholar working on Surgery, Epidemiology and Transplantation. According to data from OpenAlex, Karl Lemström has authored 159 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Surgery, 38 papers in Epidemiology and 33 papers in Transplantation. Recurrent topics in Karl Lemström's work include Transplantation: Methods and Outcomes (93 papers), Cytomegalovirus and herpesvirus research (33 papers) and Renal Transplantation Outcomes and Treatments (24 papers). Karl Lemström is often cited by papers focused on Transplantation: Methods and Outcomes (93 papers), Cytomegalovirus and herpesvirus research (33 papers) and Renal Transplantation Outcomes and Treatments (24 papers). Karl Lemström collaborates with scholars based in Finland, Switzerland and Netherlands. Karl Lemström's co-authors include Petri Koskinen, P Häyry, Antti I. Nykänen, R. Krebs, Jussi Tikkanen, Kari Alitalo, I Lautenschlager, Raimo Tuuminen, C. A. Bruggeman and Roope Sihvola and has published in prestigious journals such as Circulation, Journal of Clinical Investigation and The Journal of Experimental Medicine.

In The Last Decade

Karl Lemström

149 papers receiving 3.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karl Lemström Finland 36 1.7k 857 854 723 703 159 3.6k
Petri Koskinen Finland 35 1.3k 0.7× 1.0k 1.2× 494 0.6× 811 1.1× 534 0.8× 123 3.1k
Willem Weimar Netherlands 35 1.2k 0.7× 475 0.6× 553 0.6× 1.2k 1.6× 1.1k 1.5× 108 3.6k
Konrad Höetzenecker Austria 32 1.5k 0.9× 401 0.5× 700 0.8× 297 0.4× 589 0.8× 216 3.6k
Yves Castier France 34 1.8k 1.1× 703 0.8× 867 1.0× 196 0.3× 575 0.8× 193 4.7k
W. Weimar Netherlands 28 924 0.5× 400 0.5× 389 0.5× 852 1.2× 927 1.3× 137 2.7k
Leena Krogerus Finland 32 1.3k 0.8× 603 0.7× 359 0.4× 859 1.2× 319 0.5× 125 3.1k
Gayle L. Winters United States 19 1.8k 1.0× 316 0.4× 257 0.3× 753 1.0× 371 0.5× 41 2.6k
Heinz Regele Austria 45 2.4k 1.4× 689 0.8× 1.2k 1.4× 3.4k 4.7× 1.8k 2.6× 188 6.9k
Alexander F. Schaapherder Netherlands 31 1.8k 1.0× 257 0.3× 472 0.6× 566 0.8× 455 0.6× 90 3.0k
Boudewijn Van Damme Belgium 37 1.3k 0.8× 461 0.5× 894 1.0× 544 0.8× 361 0.5× 126 4.2k

Countries citing papers authored by Karl Lemström

Since Specialization
Citations

This map shows the geographic impact of Karl Lemström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karl Lemström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karl Lemström more than expected).

Fields of papers citing papers by Karl Lemström

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karl Lemström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karl Lemström. The network helps show where Karl Lemström may publish in the future.

Co-authorship network of co-authors of Karl Lemström

This figure shows the co-authorship network connecting the top 25 collaborators of Karl Lemström. A scholar is included among the top collaborators of Karl Lemström based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karl Lemström. Karl Lemström is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Syrjälä, S., Kishor Dhaygude, Raimo Tuuminen, et al.. (2024). Donor plasma VEGF-A as a biomarker for myocardial injury and primary graft dysfunction after heart transplantation. The Journal of Heart and Lung Transplantation. 43(10). 1677–1690. 1 indexed citations
2.
Dhaygude, Kishor, R. Krebs, Maija Puhka, et al.. (2023). Transcriptomic Landscape of Circulating Extracellular Vesicles in Heart Transplant Ischemia–Reperfusion. Genes. 14(11). 2101–2101. 2 indexed citations
3.
Syrjälä, S., Kishor Dhaygude, Raimo Tuuminen, et al.. (2023). Severe primary graft dysfunction of the heart transplant is associated with increased plasma and intragraft proinflammatory cytokine expression. The Journal of Heart and Lung Transplantation. 42(6). 807–818. 8 indexed citations
4.
Helanterä, Ilkka, Karl Lemström, S. Syrjälä, et al.. (2020). Randomised sham-controlled double-blind trial evaluating remote ischaemic preconditioning in solid organ transplantation: a study protocol for the RIPTRANS trial. BMJ Open. 10(11). e038340–e038340. 2 indexed citations
5.
Keränen, Mikko, Alireza Raissadati, Antti I. Nykänen, et al.. (2016). Increased myeloid cell hypoxia-inducible factor-1 delays obliterative airway disease in the mouse. The Journal of Heart and Lung Transplantation. 35(5). 671–678. 2 indexed citations
6.
Raissadati, Alireza, S. Syrjälä, Georgia Zarkada, et al.. (2015). Ischemia–Reperfusion Injury Enhances Lymphatic Endothelial VEGFR3 and Rejection in Cardiac Allografts. American Journal of Transplantation. 16(4). 1160–1172. 37 indexed citations
7.
Hämmäinen, Pekka, Karl Lemström, Janne J. Jokinen, et al.. (2013). H1N1 influenza, ECMO and Double Lung Transplantation. Should selected refractory acute lung failure patients be transplanted?. Annals of Saudi Medicine. 33(2). 1 indexed citations
8.
Dellgren, Göran, Odd Geiran, Karl Lemström, et al.. (2012). Three Decades of Heart Transplantation in Scandinavia: Long-Term Follow-Up. European Journal of Heart Failure. 15(3). 308–315. 39 indexed citations
9.
Tikkanen, Jussi, Maria Hollmén, Antti I. Nykänen, et al.. (2006). Role of Platelet-derived Growth Factor and Vascular Endothelial Growth Factor in Obliterative Airway Disease. American Journal of Respiratory and Critical Care Medicine. 174(10). 1145–1152. 27 indexed citations
10.
Krebs, R., Jussi Tikkanen, Antti I. Nykänen, et al.. (2005). Dual Role of Vascular Endothelial Growth Factor in Experimental Obliterative Bronchiolitis. American Journal of Respiratory and Critical Care Medicine. 171(12). 1421–1429. 37 indexed citations
11.
Tikkanen, Jussi, et al.. (2002). Blockade of CD28/B7-2 Costimulation Inhibits Experimental Obliterative Bronchiolitis in Rat Tracheal Allografts: Suppression of Helper T Cell Type1-dominated Immune Response. American Journal of Respiratory and Critical Care Medicine. 165(5). 724–729. 37 indexed citations
12.
Tikkanen, Jussi, et al.. (2001). Prevention of Cytomegalovirus Infection–enhanced Experimental Obliterative Bronchiolitis by Antiviral Prophylaxis or Immunosuppression in Rat Tracheal Allografts. American Journal of Respiratory and Critical Care Medicine. 164(4). 672–679. 30 indexed citations
13.
Lemström, Karl, Roope Sihvola, Jussi Tikkanen, et al.. (2001). PDGF receptor inhibition prevents cardiac allograft arteriosclerosis in cholesterol-fed rabbits. Transplantation Proceedings. 33(1-2). 318–318. 6 indexed citations
14.
Tikkanen, Jussi, Karl Lemström, & Petri Koskinen. (2001). CD28–B7-2 but not CD28–B7-1 interaction is required for T cell costimulation in experimental obliterative bronchiolitis in the rat. Transplantation Proceedings. 33(1-2). 535–535. 1 indexed citations
15.
Lemström, Karl, et al.. (2000). Blockade of Complement Inhibits Obliterative Bronchiolitis in Rat Tracheal Allografts. American Journal of Respiratory and Critical Care Medicine. 161(4). 1332–1339. 28 indexed citations
16.
Aavik, Einari, et al.. (1999). Role of Platelet-derived Growth Factor in Obliterative Bronchiolitis (Chronic Rejection) in the Rat. American Journal of Respiratory and Critical Care Medicine. 160(4). 1324–1332. 44 indexed citations
17.
Koskinen, Petri, et al.. (1997). Cytomegalovirus Infection Enhances Experimental Obliterative Bronchiolitis in Rat Tracheal Allografts. American Journal of Respiratory and Critical Care Medicine. 155(6). 2078–2088. 26 indexed citations
18.
Koskinen, Petri, et al.. (1997). A Dose-Dependent Inhibitory Effect of Cyclosporine A on Obliterative Bronchiolitis of Rat Tracheal Allografts. American Journal of Respiratory and Critical Care Medicine. 155(1). 303–312. 46 indexed citations
19.
Lemström, Karl, Petri Koskinen, JOHAN HENDRIK BRUNING, et al.. (1994). Effect of ganciclovir prophylaxis on cytomegalovirus-enhanced allograft arteriosclerosis. Transplant International. 7(s1). 383–384. 11 indexed citations
20.
Häyry, P, et al.. (1988). Problem of chronic rejection.. 1. 154–160. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Petri Koskinen Breakdown of academic impact, for papers by Willem Weimar Breakdown of academic impact, for papers by Konrad Höetzenecker Breakdown of academic impact, for papers by Yves Castier Breakdown of academic impact, for papers by W. Weimar Breakdown of academic impact, for papers by Leena Krogerus Breakdown of academic impact, for papers by Gayle L. Winters Breakdown of academic impact, for papers by Heinz Regele Breakdown of academic impact, for papers by Alexander F. Schaapherder Breakdown of academic impact, for papers by Boudewijn Van Damme
Rankless by CCL
2026